Cargando…
Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment
INTRODUCTION: The aim of this study was to evaluate the diagnostic and prognostic value of presepsin in patients with severe sepsis and septic shock during the first week of ICU treatment. METHODS: In total, 116 patients with suspected severe sepsis or septic shock were included during the first 24 ...
Autores principales: | Behnes, Michael, Bertsch, Thomas, Lepiorz, Dominic, Lang, Siegfried, Trinkmann, Frederik, Brueckmann, Martina, Borggrefe, Martin, Hoffmann, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174283/ https://www.ncbi.nlm.nih.gov/pubmed/25190134 http://dx.doi.org/10.1186/s13054-014-0507-z |
Ejemplares similares
-
Diagnostic value of Pentraxin-3 in patients with sepsis and septic shock in accordance with latest sepsis-3 definitions
por: Hamed, Sonja, et al.
Publicado: (2017) -
Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial
por: Pietrasanta, Carlo, et al.
Publicado: (2021) -
Alterations of leptin in the course of inflammation and severe sepsis
por: Behnes, Michael, et al.
Publicado: (2012) -
Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2012) -
Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2011)